CVA Family Office’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $284K | Sell |
2,646
-22
| -0.8% | -$2.36K | 0.04% | 235 |
|
|
2025
Q1 | $269K | Buy |
2,668
+247
| +10% | +$24.9K | 0.04% | 232 |
|
|
2024
Q4 | $216K | Buy |
2,421
+481
| +25% | +$43K | 0.03% | 262 |
|
|
2024
Q3 | $163K | Buy |
1,940
+31
| +2% | +$2.6K | 0.03% | 295 |
|
|
2024
Q2 | $147K | Buy |
1,909
+131
| +7% | +$10.1K | 0.03% | 290 |
|
|
2024
Q1 | $122K | Buy |
1,778
+8
| +0.5% | +$548 | 0.02% | 324 |
|
|
2023
Q4 | $102K | Buy |
+1,770
| New | +$102K | 0.02% | 331 |
|
|
2023
Q3 | – | Sell |
-1,992
| Closed | -$108K | – | 328 |
|
|
2023
Q2 | $108K | Buy |
1,992
+252
| +14% | +$13.6K | 0.02% | 302 |
|
|
2023
Q1 | $87.1K | Sell |
1,740
-30
| -2% | -$1.5K | 0.02% | 333 |
|
|
2022
Q4 | $81.9K | Buy |
1,770
+770
| +77% | +$35.6K | 0.02% | 309 |
|
|
2022
Q3 | $39K | Buy |
1,000
+905
| +953% | +$35.3K | 0.01% | 421 |
|
|
2022
Q2 | $4K | Sell |
95
-2,020
| -96% | -$85.1K | ﹤0.01% | 757 |
|
|
2022
Q1 | $94K | Buy |
2,115
+1,455
| +220% | +$64.7K | 0.02% | 268 |
|
|
2021
Q4 | $28K | Buy |
+660
| New | +$28K | 0.01% | 467 |
|
|
2021
Q3 | – | Sell |
-1,885
| Closed | -$81K | – | 431 |
|
|
2021
Q2 | $81K | Buy |
1,885
+1,340
| +246% | +$57.6K | 0.02% | 272 |
|
|
2021
Q1 | $21K | Buy |
+545
| New | +$21K | 0.01% | 400 |
|